Medicinal products for human use: Monthly figures - November 2024
Submitted by Anonymous (not verified) on 13 December 2024 - 13:15
Medicinal products for human use: Monthly figures - November 2024
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Efficacy Working Party (EWP-V) 2025
Submitted by Anonymous (not verified) on 13 December 2024 - 13:08
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Efficacy Working Party (EWP-V) 2025
Work plan for the CVMP Novel Therapies & Technologies Working Party (NTWP) 2025
Submitted by Anonymous (not verified) on 13 December 2024 - 13:03
Work plan for the CVMP Novel Therapies & Technologies Working Party (NTWP) 2025
Scientific recommendations on classification of advanced therapy medicinal products
Submitted by Anonymous (not verified) on 13 December 2024 - 13:02
Scientific recommendations on classification of advanced therapy medicinal products
Public call for expression of interest for experts to become members of the European Medicines Agency's scientific advisory groups
Submitted by Anonymous (not verified) on 13 December 2024 - 13:00
Public call for expression of interest for experts to become members of the European Medicines Agency's scientific advisory groups
Human medicines European public assessment report (EPAR): Bamlanivimab and etesevimab for COVID-19, Status: Withdrawn (during rolling review)
Submitted by Anonymous (not verified) on 13 December 2024 - 12:03
Human medicines European public assessment report (EPAR): Bamlanivimab and etesevimab for COVID-19, Status: Withdrawn (during rolling review)
Public-health advice on COVID-19 medicines
Submitted by Anonymous (not verified) on 13 December 2024 - 11:28
Public-health advice on COVID-19 medicines
ETF statement on the loss of activity of anti-spike protein monoclonal antibodies due to emerging SARS-CoV-2 variants: December 2024 update
Submitted by Anonymous (not verified) on 13 December 2024 - 11:27
ETF statement on the loss of activity of anti-spike protein monoclonal antibodies due to emerging SARS-CoV-2 variants: December 2024 update
Summary of opinion: Bridion, 12/12/2024 Positive
Submitted by Anonymous (not verified) on 13 December 2024 - 11:22
Summary of opinion: Bridion, 12/12/2024 Positive
Summary of opinion: Rekambys, 12/12/2024 Positive
Submitted by Anonymous (not verified) on 13 December 2024 - 11:13
Summary of opinion: Rekambys, 12/12/2024 Positive